The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence

Author： Gu Jian Barton Grossman H Dinney Colin P Wu Xifeng

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.6, 2005-09, pp. : 575-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of proteomics on bladder cancer research

By Celis Julio E Gromova Irina Moreira Jose MA Cabezon Teresa Gromov Pavel

Pharmacogenomics, Vol. 5, Iss. 4, 2004-06 ,pp. : 381-394

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic candidate genes for melanoma

By Hull Christopher Larson April Leachman Sancy

Pharmacogenomics, Vol. 4, Iss. 6, 2003-11 ,pp. : 753-765

Future Medicine

Access to resources Recommend Favorite

Identification of Bladder Cancer Patients at Risk for Recurrence or Progression: An Immunohistochemical Study Based on the Expression of Metallothionein

By Hinkel Andreas Schmidtchen Sonja Palisaar Rein-Jueri Noldus Joachim Pannek Jurgen

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 13-14, 2008-01 ,pp. : 954-959

Taylor & Francis Ltd

Access to resources Recommend Favorite

Detection of Bladder Cancer Recurrence with Real-time Three-dimensional Ultrasonography-based Virtual Cystoscopy

By Gulsen F Dikici S Mihmanli I Ozbayrak M Onal B Obek C Kantarci F

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2264-2272

Field House Publishing

Access to resources Recommend Favorite

Bladder Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 8-8

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite